Article and Video CATEGORIES

Cancer Journey

Search By

Ketki Patel, MHA, is a Program Operations Specialist/Post Award Specialist for the University of Washington Thoracic, Head and Neck Oncology Research Program in Seattle, Washington.

Ketki is an experienced Patient Financial Advocate with a demonstrated history of working with clinical trials/research, medical oncology, and holds knowledge in prior authorization of inpatient and outpatient chemotherapy and appealing all types of claim denials. She has experience working with the drug manufacturers for drug assistance and copay assistance in the hospital billing setting.

How to Combat Financial Toxicity During Your Cancer Treatment, Part 2
Author
Ketki Patel, MHA, GRACE Guest Contributor
As the payer landscape continuously changes so do many insurance companies and their cancer medication requirements. 

One important class of drugs that is facing constant change and is given with many traditional cancer treatments are granulocyte colony stimulating factors (G-CSF).  G-CSFs stimulate the bone marrow to produce white blood cells; which reduces the risk of infection and speeds up the recovery from neutropenia after intensive chemotherapy regimens.  Neutropenia is a condition where there are diminished numbers of neutrophils (a type of white blood cell that aids in your bodies immunity in fighting against infection) in the blood.

G-CSFs can either be given in the hospital setting or can be given as self-administered/injected home medication. There are two main categories these agents can be divided into; long acting and short acting. For example, Neulasta (pegfilgastrim) is generally given after chemotherapy to stimulate the growth of new and healthy white blood cells with a 14-day interval between injections (either given in the provider’s office or in the infusion center).  Neupogen (filgastrim) on the other hand, can be given daily (either self-injected, in the provider’s office, or in the infusion center). It is important for patients to be aware of these nuances as some insurance companies require these medications to be sent from a mail order pharmacy if they cannot be picked up from a specialty pharmacy.

Most recently a number of biosimilars (a biologic product that is almost an identical copy of the original drug that is manufactured by a different company) have been gaining FDA approval and gaining popularity within insurance formularies.  For example, some insurance companies are requiring that biosimilars of Neulasta, which include Udenyca and Fulphila, to be tried and failed first prior to using Neulasta.  For Neupogen, these options could include Zarxio and Nivestym. A drug that is also comparable to Neupogen and is often prescribed in the same way is Granix.

This whole process can become really complicated as each insurance company will have their own formulary option. It is therefore important to understand the differences, albeit slight, that could impact the cost of your care. 

Many insurance companies follow step therapy requirements or have formulary requirements when it comes to this class of drugs. 

A formulary is generally a preferred list of particular medications that are approved to be prescribed at a particular hospital, in a particular health system, or under a particular health insurance policy.  The health plan formulary is usually created to recommend the most cost-effective medication option for the health condition in question.  The health plan may also have a formulary tier, the lowest tier (usually Tier 1) having the lowest cost-sharing option, and the highest tier (usually Tier 4 or 5) having the highest cost sharing option. 

Step therapy requirements is the process in which your health plan requires a certain medication is used first prior to using another, usually more costly option, for the health condition.

Health insurance plans will all have different formularies and copays and coinsurances, all of which will be provided to you after you enroll or as soon as your benefits start.  It’s also important to speak with your provider if you have concerns related to cost and see if there are cheaper alternatives.  Lastly, if your provider’s office has a Patient Financial Advocate (PFAs) please reach out to them to help identify insurance requirements as they may already be aware of these nuances. A PFA can also help you find copay assistance and drug assistance options, either through the manufacturer or third-party foundations, should your insurance not provide adequate coverage.

Do you have questions for Ketki?  Please join the conversation in our community forums! https://cancergrace.org/forum/how-combat-financial-toxicity-during-your-cancer-treatment-what-do-you-think

*Please note:  The below links are information only and GRACE has no financial relationship with these organizations.

Helpful Resources:

https://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/biosimilars/ucm580432.htm

http://www.fulphila.com/

http://www.granixrx.com/

https://www.neulasta.com/

https://www.neupogen.com/

https://www.nivestym.com/

https://udenyca.com/coherus-complete/

https://www.zarxio.com/patient/


 

*Please note that this information is not affiliated with Swedish Cancer Institute

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Formas de hacer frente a las consecuencias del cuidado de otras personas   En esta sección, analizamos posibles medidas que podemos tomar para apoyarnos en las luchas que supone ser cuidador.   Tomarse un descanso/ Encontrar el "tiempo para mí"   Cuidar de alguien parece una ocupación a tiempo completo, pero no tiene por qué serlo. Cuidar de uno mismo nos prepara para desempeñar mejor nuestro papel.
Article
El apoyo y el cuidador   Cuidando a un cuidador Cuando llegan los informes de las pruebas y la creciente expectación confirma los peores temores con un diagnóstico de cáncer, sin duda a quien más afecta es al individuo. Sin embargo, sus ondas son de gran alcance; lo compartimos con nuestros padres, familiares, parejas, hijos o amigos, y casi cualquier persona en la que podamos confiar en busca de apoyo.   
Article
Support and the Caregiver Caring for a Caregiver

Forum Discussions

Hi Oaktowngrrl,  Welcome to Grace.  I'm so sorry you're going through this.

 

 Finding a reputable dedicated thoracic surgeon for lung surgery might be difficult, as it is a complex and...

Hello Hello,  Just want to let you know I see your post and will respond more appropriately in the morning. 

Hi, I'm sorry for the delay.  It's OK to post with questions here, it's what the forums are for.  However, our expertise is not in diagnosing cancer but in knowledge of...

Recent Comments

JOIN THE CONVERSATION
Hi Oaktowngrrl,  Welcome to…
By JanineT GRACE … on
I can understand why you're…
By paulryan on
I'm so sorry to hear it.
By Andrian on
Hey,

 I'm sure you're…
By JanineT GRACE … on